|
|
|
Volumn 2016, Issue , 2016, Pages 24-27
|
|
Preventing phase III failures
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
PACLITAXEL;
PRESCRIPTION DRUG;
CLINICAL EVALUATION;
CLINICAL STUDY;
DATA ANALYSIS;
DRUG COST;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
GOOD CLINICAL PRACTICE;
HEALTH CARE;
HEALTH CARE SYSTEM;
HUMAN;
INFORMATION PROCESSING;
NOTE;
PHASE 3 CLINICAL TRIAL (TOPIC);
PROCESS DEVELOPMENT;
STUDY DESIGN;
|
|
EID: 85018484695
PISSN: 15432521
EISSN: 21507376
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (6)
|
|
References (7)
|
